White label ELPA - ClinicalTrials.eu

A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

Recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- HLX43
A study to evaluate the effects of N-Acetyl-L-Leucine in patients with CACNA1A disorders

Recruiting

3 1
Investigated Diseases:
- Neurodevelopmental disorder
Investigated Drugs:
- L-Acetylleucine
Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Recruiting

3 1
Investigated Diseases:
- Conjunctivitis
- Conjunctivitis allergic
Investigated Drugs:
Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

Recruiting

3 1
Investigated Diseases:
- Conjunctivitis
- Conjunctivitis allergic
Investigated Drugs:
A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

Recruiting

3 1
Investigated Diseases:
- Pulmonary hypertension
Investigated Drugs:
- Levosimendan
+3
Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- [18F]DED
A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata

Recruiting

2 1
Investigated Diseases:
- Alopecia areata
A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Recruiting

3 1 1
Investigated Drugs:
+2
Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

Recruiting

3 1
Investigated Diseases:
- Obstructive sleep apnoea syndrome
A Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer

Recruiting

3 1 1 1
Investigated Drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies